Quince Therapeutics, Inc. (QNCX) › Capital ExpendituresQuince Therapeutics, Inc. (QNCX) — Capital ExpendituresAnnual figures by fiscal year, from SEC filings.2018: $212.0K2019: $55.0K2020: $52.0K2021: $180.0K2022: $133.0K2023: $160.0K2024: $257.0K2025: $352.0K$352.0K2018Capital Expenditures (USD)2025Fiscal YearCapital ExpendituresChange YoY2025$352.0K+37.0%2024$257.0K+60.6%2023$160.0K+20.3%2022$133.0K-26.1%2021$180.0K+246.2%2020$52.0K-5.5%2019$55.0K-74.1%2018$212.0K—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowShares OutstandingDividends Per Share